These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 365378)

  • 1. Anticonvulsant activity and effects of sodium dipropylacetate on cerebral 5-hydroxytryptamine and gamma-aminobutyric acid in reserpinized mice.
    Kukino K; Deguchi T
    Chem Pharm Bull (Tokyo); 1978 Nov; 26(11):3551-5. PubMed ID: 365378
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of valproic acid on levels of GABA and glutamic acid in pentylenetetrazole-damaged rat brain.
    Calderón Guzmán D; Espitia Vázquez I; Barragán Mejía G; Labra Ruiz N; Rodríguez Pérez R; Santamaria del Angel D; Ayala Guerrero F; Juárez Olguín H
    Proc West Pharmacol Soc; 2003; 46():48-50. PubMed ID: 14699883
    [No Abstract]   [Full Text] [Related]  

  • 3. Time course of the increase in GABA level in different mice brain regions following N-dipropylacetate treatment.
    Simler S; Gensburger C; Ciesielski L; Mandel P
    Commun Psychopharmacol; 1978; 2(2):123-30. PubMed ID: 352606
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of sodium dipropylacetate on gamma-aminobutyric acid and biogenic amines in rat brain.
    Kukino K; Deguchi T
    Chem Pharm Bull (Tokyo); 1977 Sep; 25(9):2257-62. PubMed ID: 338171
    [No Abstract]   [Full Text] [Related]  

  • 5. The effects of analogues of valproic acid on seizures induced by pentylenetetrazol and GABA content in brain of mice.
    Keane PE; Simiand J; Mendes E; Santucci V; Morre M
    Neuropharmacology; 1983 Jul; 22(7):875-9. PubMed ID: 6413882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proceedings: gamma-Aminobutyric acid metabolism and the anticonvulsant action of ethanolamine-o-sulphate and di-n-propylacetate.
    Anlezark GM; Horton RW; Meldrum BS; Sawaya MC; Stephenson JD
    Br J Pharmacol; 1976 Mar; 56(3):383P-384P. PubMed ID: 769882
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of chronic treatment with amino-oxyacetic acid or sodium n-dipropylacetate on brain GABA levels and the development and regression of cobalt epileptic foci in rats.
    Emson PC
    J Neurochem; 1976 Dec; 27(6):1489-94. PubMed ID: 794443
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of valproate on brain GABA: comparison with various medium chain fatty acids.
    Keane PE; Morre M
    Pharmacol Res Commun; 1985 Jun; 17(6):547-55. PubMed ID: 3927325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of sodium valproate (VPA) on cerebral amino acids: mechanism of gamma-aminobutyric acid (GABA) elevation and possible causal relation of VPA-induced encephalopathy and glutamine level.
    Miyazaki C; Matsuyama K; Ichikawa M; Goto S
    Chem Pharm Bull (Tokyo); 1988 Sep; 36(9):3589-94. PubMed ID: 3149216
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of anticonvulsants and gamma-aminobutyric acid (GABA)-mimetic drugs on immunoreactive somatostatin and GABA contents in the rat brain.
    Nagaki S; Kato N; Minatogawa Y; Higuchi T
    Life Sci; 1990; 46(22):1587-95. PubMed ID: 1972258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticonvulsant and biochemical effects of inhibitors of GABA aminotransferase and valproic acid during subchronic treatment in mice.
    Löscher W
    Biochem Pharmacol; 1982 Mar; 31(5):837-42. PubMed ID: 6805473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute anticonvulsant activity of structural analogues of valproic acid and changes in brain GABA and aspartate content.
    Chapman AG; Meldrum BS; Mendes E
    Life Sci; 1983 Apr; 32(17):2023-31. PubMed ID: 6403794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of sodium valproate on gamma-aminobutyrate metabolism and behaviour in naive and ethanolamine-O-sulphate pretreated rats and mice.
    Phillips NI; Fowler LJ
    Biochem Pharmacol; 1982 Jul; 31(13):2257-61. PubMed ID: 6812585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoamine and GABA metabolism and the anticonvulsant action of di-n-propylacetate and ethanolamine-O-sulphate.
    Horton RW; Anlezark GM; Sawaya MC; Meldrum BS
    Eur J Pharmacol; 1977 Feb; 41(4):387-97. PubMed ID: 139317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the biological activity of sodium valproate and L-lysine valproate on brain GABA levels by (3H) muscimol radioreceptor assay.
    Brunet C; Luyckx M; Bianchi A; Paluszezak D
    Farmaco Prat; 1988 Sep; 43(9):291-6. PubMed ID: 3149246
    [No Abstract]   [Full Text] [Related]  

  • 16. Anticonvulsant properties of diacetylmonoxime (DAM) and its effect on the facilitatory action of reserpine on convulsions.
    Galambos E; Pfeifer AK
    Psychopharmacologia; 1966; 9(3):248-52. PubMed ID: 5983211
    [No Abstract]   [Full Text] [Related]  

  • 17. The relation between monoamines in brain and the anticonvulsant action of inhibition of carbonic anhydrase.
    Gray WD; Rauh CE
    J Pharmacol Exp Ther; 1971 Apr; 177(1):206-18. PubMed ID: 4254846
    [No Abstract]   [Full Text] [Related]  

  • 18. [The effect of two anticonvulsant substances on brain GABA levels. Interaction with isoniazid].
    Gerardy J
    J Pharm Belg; 1988; 43(5):364-71. PubMed ID: 3244099
    [No Abstract]   [Full Text] [Related]  

  • 19. Calcitonin potentiates the anticonvulsant and antinociceptive effects of valproic acid and pregabalin in pentylenetetrazole-kindled mice.
    Hamada NM; Ashour RH; Shalaby AA; El-Beltagi HM
    Eur J Pharmacol; 2018 Jan; 818():351-355. PubMed ID: 29104044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticonvulsant action of ethanolamine-O-sulphate and di-n-propylacetate and the metabolism of gamma-aminobutyric acid (GABA) in mice with audiogenic seizures.
    Anlezark G; Horton RW; Meldrium BS; Sawaya CB
    Biochem Pharmacol; 1976 Feb; 25(4):413-7. PubMed ID: 779794
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.